Hydrocortison Robugen (Hydrocortisone)

Hydrocortison Robugen is indicated for the topical treatment of several inflammatory and allergic skin disorders, where reduction of redness, itching, and swelling is desired.

• Eczema (atopic dermatitis)
• Contact dermatitis
• Allergic skin reactions such as insect bites or urticaria
• Other mild inflammatory skin conditions (e.g., rash, irritant dermatitis)
• Relief of itching and inflammation associated with dermatitis

• Hydrocortison Robugen delivers hydrocortisone to the skin, where the molecule diffuses into keratinocytes and immune cells and binds to intracellular glucocorticoid receptors. The receptor‑ligand complex translocates to the nucleus and interacts with glucocorticoid response elements, altering gene transcription. This down‑regulates the synthesis of pro‑inflammatory cytokines, prostaglandins, and leukotrienes, while up‑regulating anti‑inflammatory proteins, resulting in decreased local inflammation and immune activity.

Topical hydrocortisone may cause local and systemic adverse reactions, although many users experience no problems.

Common

• Mild burning or stinging at the application site
• Transient itching or irritation
• Dryness or flaking of the skin
• Acne‑like eruptions or folliculitis
• Redness that resolves with continued use

Serious

• Skin atrophy or thinning with prolonged use
• Development of telangiectasia (visible small blood vessels)
• Secondary bacterial, fungal, or viral skin infection
• Systemic cortisol suppression when large areas are treated
• Allergic contact dermatitis to the formulation
• Persistent hypopigmentation of the treated skin

Before using Hydrocortison Robugen, consider the following safety points.

• Avoid application on broken, infected, or ulcerated skin unless directed by a clinician.
• Limit use on the face, groin, or axillae due to higher risk of skin thinning.
• Do not apply occlusive dressings unless specifically instructed.
• Use the smallest effective amount for the shortest duration needed.
• Exercise caution in children and adolescents, as they may absorb more drug systemically.
• Consult a healthcare professional before use during pregnancy or lactation.
• Discontinue and seek medical advice if signs of infection or severe irritation develop.

Hydrocortison Robugen can interact with other topical or systemic agents; consider the following.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area.
• Application under occlusive dressings without medical supervision.
• Simultaneous systemic glucocorticoid therapy, which may increase systemic effects.

Use with caution

• Antifungal or antibacterial creams, as combined use may mask infection.
• Topical immunomodulators (e.g., tacrolimus) that could alter immune response.
• Phototherapy or UV treatments, which may increase skin sensitivity.
• Herbal or over‑the‑counter skin products that could cause irritation.
• Use on large body surface areas, monitoring for systemic absorption.